Organ Technology that Ignites Hope.
This Changes Everything.








We’re driven by a commitment to make organ transplants safer, easier and more accessible for people with organ failure.
Our organ technology is enhancing research at some of the world’s top institutions1 to treat diseased organs and develop technologies that may someday make transplantation the last line in a broader range of treatment options.









A Novel Liver Support System for Acute-on-Chronic Cases
In 2025, we are beginning the first in-human trial of our extracorporeal liver cross-circulation (ELC) system, co-developed with eGenesis. The trial will use eGenesis’s human-compatible, genetically engineered porcine livers. For patients with acute-on-chronic liver failure, this treatment may provide a bridge to transplant or much-needed time for their native liver to recover.
Learn MoreProfessor Stefan Schneeberger
Innsbruck Medical University, Austria
Beyond Liver, Beyond Transplantation
As we continue to develop the transformative potential of NMP technology, we’re looking ahead to take on even greater challenges and develop new technologies that will help save more lives.
OrganOx metra for Additional Organs
We’re currently working on perfusion products to support additional organs. Our NMP device for kidney transplant preservation is in development and preparing to begin clinical trials in the U.S.

NMP for Organ Support & Enhancement
With further development, NMP holds the potential to ultimately help heal organs inside or outside the body. Treating and potentially improving the quality of these organs may eventually enable clinicians to offer alternative therapies to patients for whom transplant is the only current life-saving option.


NMP for Drug Exploration
Through partnerships with biopharma manufacturers, we’re exploring new ways for our organ technology to help shorten the time needed to test new drugs for safety and effectiveness. Our platform’s potential to help make drug discovery and development more efficient and cost-effective may ultimately lead to accelerating the development timelines for a broad range of diseases.
Testing drugs on research organs outside the human body could give biopharma researchers valuable information earlier in the drug discovery process. This would enable them to refine therapies and reduce — or perhaps even eliminate — the need for animal testing, thus lowering risks to living human research subjects.
Discover Where Organ Technology Leads
Learn more about the groundbreaking potential and future implications of NMP technology and the OrganOx metra.
Get in Touch
From Our Newsroom
Keep up to date with the latest OrganOx updates and recent news in organ transplantation.
- Company Data on file